Authors:
FALLABSTUBI CL
ZELLWEGER JP
SAUTY A
ULDRY C
IORILLO D
BURNIER M
Citation: Cl. Fallabstubi et al., ELECTRONIC MONITORING OF ADHERENCE TO TREATMENT IN THE PREVENTIVE CHEMOTHERAPY OF TUBERCULOSIS, The international journal of tuberculosis and lung disease, 2(7), 1998, pp. 525-530
Authors:
BUCLIN T
SECHAUD R
BERTSCHI AP
DECOSTERD LA
BELAZ N
APPENZELLER M
BURNIER M
BIOLLAZ J
Citation: T. Buclin et al., ESTIMATION OF GLOMERULAR-FILTRATION RATE BY SINISTRIN CLEARANCE USINGVARIOUS APPROACHES, Renal failure, 20(2), 1998, pp. 267-276
Authors:
PECHEREBERTSCHI A
NUSSBERGER J
DECOSTERD L
ARMAGNAC C
SISSMANN J
BOUROUDIAN M
BRUNNER HR
BURNIER M
Citation: A. Pecherebertschi et al., RENAL RESPONSE TO THE ANGIOTENSIN-II RECEPTOR SUBTYPE-1 ANTAGONIST IRBESARTAN VERSUS ENALAPRIL IN HYPERTENSIVE PATIENTS, Journal of hypertension, 16(3), 1998, pp. 385-393
Authors:
MANUNTA P
BURNIER M
DAMICO M
BUZZI L
LANZANI C
RIVERA R
CITTERIO L
BERNARDI L
BARLASSINA C
MAILLARD M
CUSI D
BIANCHI G
Citation: P. Manunta et al., RENAL SODIUM HANDLING AND ALPHA-ADDUCIN POLYMORPHISM IN HYPERTENSIVE PATIENTS, Journal of hypertension, 16, 1998, pp. 405-405
Authors:
FRICKER AF
NUSSBERGER J
MEILENBROCK S
BRUNNER HR
BURNIER M
Citation: Af. Fricker et al., EFFECT OF INDOMETHACIN ON THE RENAL RESPONSE TO ANGIOTENSIN-II RECEPTOR BLOCKADE IN HEALTHY-SUBJECTS, Kidney international, 54(6), 1998, pp. 2089-2097
Authors:
PECHEREBERTSCHI A
NUSSBERGER J
BIOLLAZ J
FAHTI M
GROUZMANN E
MORGAN T
BRUNNER HR
BURNIER M
Citation: A. Pecherebertschi et al., CIRCADIAN VARIATIONS OF RENAL SODIUM HANDLING IN PATIENTS WITH ORTHOSTATIC HYPOTENSION, Kidney international, 54(4), 1998, pp. 1276-1282
Citation: G. Minghelli et al., URICOSURIC EFFECT OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IN HEART-TRANSPLANT RECIPIENTS, Transplantation, 66(2), 1998, pp. 268-271
Citation: M. Burnier et Hr. Brunner, ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CLINICAL DEVELOPMENT AND FUTUREPERSPECTIVES, Therapie, 53(3), 1998, pp. 279-284
Citation: Mp. Schneider et M. Burnier, ONLINE HOME MONITORING OF DRUG COMPLIANCE - IS IT FEASIBLE, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 489-490
Authors:
WANG Q
HUMMLER E
HORISBERGER JD
BURNIER M
Citation: Q. Wang et al., SALT-SENSITIVE, CYCLIC VARIATIONS IN AMILORIDE-SENSITIVE RECTAL POTENTIAL DIFFERENCE IN MICE, Journal of the American Society of Nephrology, 8, 1997, pp. 1429-1429
Authors:
FRICKER AF
MONOD ML
MEILENBROCK S
DOUGLAS J
BRUNNER HR
BURNIER M
Citation: Af. Fricker et al., EFFECT OF INDOMETHACIN ON THE RENAL RESPONSE TO THE ANGIOTENSIN-II RECEPTOR ANTAGONIST VALSARTAN IN HEALTHY-SUBJECTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1451-1451
Authors:
PECHEREBERTSCHI A
VALLOTTON M
STALDER H
BURNIER M
Citation: A. Pecherebertschi et al., ARE THERE VARIATIONS IN RETINAL SODIUM HANDLING AND BLOOD-PRESSURE RESPONSE TO CHANGES IN SODIUM-INTAKE DURING THE NORMAL MENSTRUAL-CYCLE, Journal of the American Society of Nephrology, 8, 1997, pp. 1473-1473
Authors:
HAYOZ D
WEBER R
PECHERE A
BURNIER M
BRUNNER HR
Citation: D. Hayoz et al., HETEROGENEOUS VASCULAR-RESPONSE TO VASOPRESSIN - RADIAL ARTERY VERSUSFOREARM BLOOD-FLOW, Journal of hypertension, 15(1), 1997, pp. 35-41
Authors:
WEBER R
PECHEREBERTSCHI A
HAYOZ D
GERC V
BROUARD R
LAHMY JP
BRUNNER HR
BURNIER M
Citation: R. Weber et al., EFFECTS OF SR-49059, A NEW ORALLY-ACTIVE AND SPECIFIC VASOPRESSIN V-1RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED VASOCONSTRICTION IN HUMANS, Hypertension, 30(5), 1997, pp. 1121-1127
Citation: Mr. Lesk et al., EFFECT OF ORAL THALIDOMIDE ON PROLONGATION OF RABBIT SCLEROSTOMY FUNCTION, Investigative ophthalmology & visual science, 38(4), 1997, pp. 1240-1240
Authors:
BUCLIN T
PECHEREBERTSCHI A
SECHAUD R
DECOSTERD LA
MUNAFO A
BURNIER M
BIOLLAZ J
Citation: T. Buclin et al., SINISTRIN CLEARANCE FOR DETERMINATION OF GLOMERULAR-FILTRATION RATE -A REAPPRAISAL OF VARIOUS APPROACHES USING A NEW ANALYTICAL METHOD, Journal of clinical pharmacology, 37(8), 1997, pp. 679-692
Authors:
HUMMLER E
BARKER P
TALBOT C
WANG Q
VERDUMO C
GRUBB B
GATZY J
BURNIER M
HORISBERGER JD
BEERMANN F
BOUCHER R
ROSSIER BC
Citation: E. Hummler et al., A MOUSE MODEL FOR THE RENAL SALT-WASTING SYNDROME PSEUDOHYPOALDOSTERONISM, Proceedings of the National Academy of Sciences of the United Statesof America, 94(21), 1997, pp. 11710-11715
Authors:
PECHEREBERTSCHI A
DECOSTERD L
BIOLLAZ J
SISSMANN J
BOUROUDIAN M
ARMAGNAC C
BRUNNER HR
BURNIER M
Citation: A. Pecherebertschi et al., RENAL HEMODYNAMIC-EFFECTS OF THE ANGIOTENSIN-II (ANG-II) ANTAGONIST IRBESARTAN VERSUS THOSE OF THE ACE-INHIBITOR ENALAPRIL IN HYPERTENSIVE PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1520-1520
Citation: M. Burnier et Hr. Brunner, RENAL EFFECTS OF ANGIOTENSIN-II RECEPTOR BLOCKADE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HEALTHY-SUBJECTS, Experimental nephrology, 4, 1996, pp. 41-46
Citation: M. Burnier et G. Centeno, ESCHERICHIA-COLI ENDOTOXIN INCREASES CYTOSOLIC-FREE CA2-CELLS( BY MOBILIZING INTRACELLULAR CALCIUM STORES IN CULTURED ENDOTHELIAL), Journal of endotoxin research, 3(2), 1996, pp. 119-127
Authors:
WAEBER B
BURNIER M
NUSSBERGER J
BRUNNER HR
Citation: B. Waeber et al., EXPERIENCE WITH ANGIOTENSIN-II ANTAGONISTS IN HYPERTENSIVE PATIENTS, Clinical and experimental pharmacology and physiology, 23, 1996, pp. 142-146